A double-blind, randomized phase II study of dicycloplatin plus paclitaxel versus carboplatin plus paclitaxel as first-line therapy for patients with advanced non-small-cell lung cancers
about
A retrospective analysis of cisplatin, pemetrexed, and bevacizumab in previously treated non-small-cell lung cancerEfficacy of cisplatin/pemetrexed with bevacizumab to treat advanced lung adenocarcinoma with different drive genes: case report and literature reviewKinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed.
P2860
A double-blind, randomized phase II study of dicycloplatin plus paclitaxel versus carboplatin plus paclitaxel as first-line therapy for patients with advanced non-small-cell lung cancers
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A double-blind, randomized pha ...... ed non-small-cell lung cancers
@ast
A double-blind, randomized pha ...... ed non-small-cell lung cancers
@en
A double-blind, randomized pha ...... ed non-small-cell lung cancers
@nl
type
label
A double-blind, randomized pha ...... ed non-small-cell lung cancers
@ast
A double-blind, randomized pha ...... ed non-small-cell lung cancers
@en
A double-blind, randomized pha ...... ed non-small-cell lung cancers
@nl
prefLabel
A double-blind, randomized pha ...... ed non-small-cell lung cancers
@ast
A double-blind, randomized pha ...... ed non-small-cell lung cancers
@en
A double-blind, randomized pha ...... ed non-small-cell lung cancers
@nl
P2093
P2860
P356
P1476
A double-blind, randomized pha ...... ed non-small-cell lung cancers
@en
P2093
Cai-Cun Zhou
Chang-Ping Wu
Hai-Ying Wu
Ji-Feng Feng
Jian-Ping Xiong
Ke-Jun Liu
Meng-Zhao Wang
P2860
P304
P356
10.5114/AOMS.2014.44862
P577
2014-08-01T00:00:00Z